| ISIN | LU2908736908 |
|---|---|
| Valor Number | 138573886 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (LU) Equity Fund Sustainable Healthy Longevity GT CHF |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | Swisscanto Fondsleitung AG |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The total commitments of the fund may not amount to more than 210% as a result of the use of derivatives (max. 100%) and temporary borrowing (max. 10%). |
| Peculiarities |
| Current Price * | 92.95 CHF | 30.10.2025 |
|---|---|---|
| Previous Price * | 92.08 CHF | 29.10.2025 |
| 52 Week High * | 105.36 CHF | 30.01.2025 |
| 52 Week Low * | 86.94 CHF | 11.04.2025 |
| NAV * | 92.95 CHF | 30.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 80,936,417 | |
| Unit/Share Assets *** | 9,009 | |
| Trading Information SIX | ||
| YTD Performance | -5.90% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| 1 month | +3.08% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | +2.17% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +1.21% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | -7.66% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | -7.05% |
02.10.2024 - 30.10.2025
02.10.2024 30.10.2025 |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | 88.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fresenius SE & Co KGaA | 4.05% | |
|---|---|---|
| CVS Health Corp | 3.30% | |
| AbbVie Inc | 3.08% | |
| Johnson & Johnson | 2.95% | |
| Abbott Laboratories | 2.88% | |
| Edwards Lifesciences Corp | 2.80% | |
| Halma PLC | 2.75% | |
| AstraZeneca PLC | 2.71% | |
| Encompass Health Corp | 2.68% | |
| Welltower Inc | 2.68% | |
| Last data update | 30.09.2025 | |
| TER | 0.76% |
|---|---|
| TER date | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.30% |
| Ongoing Charges *** | 0.76% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |